[Mastopathy after estradiol and pantoprazol treatment].
Piedra Cerezal
A
A
Sánchez Alvarez
L
L
Manso Rodríguez
G
G
Hidalgo Balsera
A
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D001562:Benzimidazoles / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000009:adverse effects*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000139:chemically induced*; D006801:Humans; D009853:Omeprazole / Q000031:analogs & derivatives; D000077402:Pantoprazole; D013454:Sulfoxides / Q000009:adverse effects*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D013454:Sulfoxides; D004958:Estradiol; D000077402:Pantoprazole; D009853:Omeprazole